Posts filtered by tags: Venture-capital[x]


 

It’s “bullshit” that VCs are open for business right now (but that could change in a month)

This afternoon, the law firm Fenwick & West hosted a virtual roundtable discussion with New York-based venture capitalists: Hadley Harris, a founding general partner with Eniac Ventures; Brad Svrluga, a cofounder and general partner of Primary Ventures; and Ellie Wheeler, a partner with Greylock. Each investor is experiencing the coronavirus-driven lockdown in unique and even positive ways. Their professional experiences were very much in sync, however, and founders should know the bottom line i...
Tags: TC, New York, Tech, Wheeler, Venture Capital, Greylock, Eniac Ventures, HARRIS, Fenwick West, Fenwick, Ellie Wheeler, Primary Ventures, Hadley Harris, Brad Svrluga, Svrluga, Greylock Svrluga


Seeqc raises $5M to help make quantum computing commercially viable

Seeqc, a startup that is part of a relatively new class of quantum computing companies that is looking at how to best use classical computing to manage quantum processors, today announced that it has raised $5 million from M Ventures, the strategic corporate venture capital arm of Merck, the German pharmaceutical giant. Merck will be a strategic partner for Seeqc and will help it to develop its R&D efforts to develop useful application-specific quantum computers. With this, New York state-bas...
Tags: Energy, Startups, TC, New York, New York City, Tech, Merck, Venture Capital, Emerging-technologies, Qubit, Quantum Mechanics, BlueYard Capital, M Ventures, HYPRES, John Levy, D-Wave Systems


12 major league edtech VCs discuss top trends, opportunities

Ready or not, edtech has been shoved into the spotlight as millions of students shifted to remote learning due to pandemic-related school shutdowns. But backing these companies are investors who have long believed that edtech was always set up for great returns and a big impact. We reached out to several to find out about which trends they’ve been willing to put their money behind. (And frankly, what we’ve been missing.) We got into how tech can help — or hurt — underserved students struggling t...
Tags: Fundings & Exits, Startups, TC, Asia, Education, Funding, US, Tech, Venture Capital, TechStars, Lightspeed Venture Partners, Jenny Lee, Reach Capital, Marlon Nichols, Jennifer Carolan, GGV


Your Friendly Tech Bro Might Be Looking for a Loan

Many venture capitalists don’t want to attract pitchfork anger from those who think the well-to-do of tech should permanently social distance themselves from stimulus money.
Tags: News, Small Business, Venture Capital, Airbnb, Relief, Start-ups, Small Business Administration, Layoffs and Job Reductions, Coronavirus (2019-nCoV, Coronavirus Aid, and Economic Security Act (2020


Bessemer’s Tess Hatch on the evolving aerospace market and COVID-19 adjustments

The aerospace market is evolving quickly and merging with other segments of tech, making it an exciting space for both startups and investors — but the complications of the global pandemic are being felt by both. Bessemer Venture Partners investor Tess Hatch has been helping guide companies in their portfolio through these strange times, and has been rolling with the punches herself. Hatch recently spoke to us about the investment advice she’s been offering, which companies are being hit hard...
Tags: Startups, TC, Space, Tech, Drones, Satellites, Venture Capital, Aerospace, Bessemer Venture Partners, Bessemer, Hatch, Tess Hatch, Extra Crunch, Coronavirus, COVID-19


Should Tech Start-Ups Take Government Loans?

Many venture capitalists don’t want to attract pitchfork anger from those who think the well-to-do of tech should permanently social distance themselves from stimulus money.
Tags: News, Small Business, Venture Capital, Airbnb, Relief, Start-ups, Small Business Administration, Layoffs and Job Reductions, Coronavirus (2019-nCoV, Coronavirus Aid, and Economic Security Act (2020


TechCrunch Live: Join USV Managing Director Albert Wenger for a live chat Thursday at 9am PDT

Startups big and small, across all industries, are affected by the novel coronavirus pandemic. From Etsy to MongoDB, from Twilio to Foursquare, these companies are looking for ways to capitalize and ultimately thrive in what has become a survivalist landscape. These companies also happen to be portfolio companies of one, Albert Wenger . We’re excited to have Union Square Ventures’ Managing Director Albert Wenger join us for a live discussion on the impacts of COVID-19 on the firm, the advic...
Tags: Startups, TC, Yahoo, Etsy, Tech, USV, Wenger, Venture Capital, PPP, Twilio, Union Square Ventures, Albert Wenger, Telebanc


How one European VC firm is reacting to the economic crisis

Public markets around the world have been tanking for the past few weeks, and many companies simply can’t operate during a lockdown. Sheltering in place has had some terrible economic consequences, with a record number of Americans getting laid off, including many startup employees. But what is happening in Europe? You might also be wondering whether European tech startups have to lay off a significant chunk of their workforce and whether financial capital has become scarce. That’s why I interv...
Tags: Startups, Europe, France, Tech, Venture Capital, Kima Ventures, Jean De La Rochebrochard, Xavier Niel, Market Analysis, Extra Crunch, Coronavirus, COVID-19


This low-flying growth equity firm, with payments and logistics bets, just closed a $257 million fund

Activant Capital, a seven-year-old, Greenwich, Conn.-based growth equity firm that’s still making a name for itself, has managed to secure $257 million in fresh capital commitments, despite that the U.S. economy appears to be headed into a recession. It’s something of a coup for founder Steve Sarracino. It also begs the question: Who is Steve Sarracino, and why are people trusting him and his 10-person firm with their investing dollars? To find out more, we reached him last week at his home, w...
Tags: Amazon, TC, Funding, San Francisco, Tech, Nike, Venture Capital, Bolt, Sequoia Capital, Mckinsey, GREENWICH Conn, American Capital, Ryan Petersen, Activant Capital, Shopify WooCommerce, Serent Capital


This low-flying growth equity firm, with payments and logistics bets, just closed a $255 million fund

Activant Capital, a seven-year-old, Greenwich, Ct.-based growth equity firm that’s still making a name for itself, has managed to secure $255 million in fresh capital commitments, despite that the U.S. economy appears to be headed into a recession. It’s something of a coup for founder Steve Sarracino. It also begs the question: who is Steve Sarracino, and why are people trusting him and his 10-person firm with their investing dollars? To find out more, we reached him last week at his home, where...
Tags: Amazon, TC, San Francisco, Tech, Nike, Venture Capital, Bolt, Sequoia Capital, Greenwich, Mckinsey, American Capital, Ryan Petersen, Activant Capital, Shopify WooCommerce, Serent Capital, Steve Sarracino


Airbnb acquires $1B in debt, equity funding to fuel post-virus plans

The funds will be used to recruit hosts, introduce longer-term stays, and bolster the company's Airbnb Experiences program.
Tags: Radio, Venture Capital, Airbnb, Silver Lake, Industry News, Select, Debt Funding, Equity Funding, Short-term Rental, Funding Round, Property Portfolio, Sixth Street Partners, Short-term Rental Market


Investor survey results: Upcoming trends in social startups

Voice-based social networks and gaming as a new form of identity were amongst the top emerging trends in consumer social startups, according to an Extra Crunch survey of top social tech investors. Meanwhile, anonymity and dating apps with a superfluous twist were spaces where investors were most pessimistic. Extra Crunch assembled a list of the most prolific and well-respected investors in social. Many have funded or worked for the breakout companies changing the way we interact with other peopl...
Tags: Social, Fundings & Exits, Startups, TC, Social Networks, Funding, Tech, Venture Capital, Andreessen Horowitz, Marketplaces, CRV, Investor Surveys, Investor Survey, Moore Justine Moore


Another major fintech exit as SoFi acquires banking and payments platform Galileo for $1.2B

The fintech wars continue to heat up with another major exit in the space. Consumer financial services platform SoFi announced today that it is acquiring payments and bank account infrastructure company Galileo for $1.2 billion in total cash and stock. The acquisition is dependent on customary closing conditions. Salt Lake City-based Galileo was founded in 2000 by Clay Wilkes and was bootstrapped to profitability over the intervening two decades. My colleague Jon Shieber wrote a profile of Galil...
Tags: Startups, Finance, Tech, Qatar, United Kingdom, Gm, Venture Capital, Anthony Noto, Salt Lake City, Payments, Plaid, Fintech, SoFi, Accel Partners, Accel, Visa


WeWork sues SoftBank in intensifying crisis over canceled $3B tender offer

Just days after SoftBank for WeWork shares that would have bought out some of the equity held by the company’s co-founder Adam Neumann along with venture capital firms like Benchmark and many individual company employees, the company is now retaliating, suing SoftBank over alleged breach of contract and breach of fiduciary duty. In a press statement this morning, the Special Committee of WeWork’s board said that it “regrets the fact that SoftBank continues to put its own interests a...
Tags: Softbank, Tech, Venture Capital, WeWork, Benchmark, Adam Neumann, SoftBank Group, Special Committee, Adam Neumann SoftBank, Special Committee of WeWork, Delaware Chancery Court WeWork


Airbnb Raises $1 Billion to Stockpile Cash in Pandemic

The home rental company raised new funding as its business has been roiled by the coronavirus.
Tags: News, Venture Capital, Private Equity, Airbnb, Brian, Start-ups, Chesky, Silver Lake Partners, Layoffs and Job Reductions, Initial Public Offerings, Hotels and Travel Lodgings, Travel and Vacations, Coronavirus (2019-nCoV


Why AI startups’ economics will likely improve over time

Hello and welcome back to our regular morning look at private companies, public markets and the gray space in between. If you can recall February, we dug into the question of AI startup gross margins. Venture shop a16z had published an interesting blog on the subject, arguing that it may be the case that AI-focused startups will enjoy strong gross margins, but perhaps not as strong as those posted by SaaS companies. Modern software startups (SaaS companies) have some of the highest gross margins...
Tags: Startups, TC, Tech, Artificial Intelligence, United States, Venture Capital, Ai, Blumberg Capital, David Blumberg, A16z


New guidance on SBA loans means most startups are still excluded from $349 billion stimulus

Under new guidance issued by the Small Business Administration it seems non-profits and faith-based groups can apply for the Paycheck Protection Program loans designed to keep small business afloat during the COVID-19 epidemic, but most venture-backed companies are still not covered. Late Friday night, the Treasury Department updated its rules regarding the “affiliation” of private entities to include religious organizations but keep in place the same rules that would deny most startups from rec...
Tags: TC, Money, Obama, Congress, Entrepreneurship, Finance, US, America, Los Angeles, Tech, Investment, United States, President, Venture Capital, Treasury, Private Equity


Insight closes $9.5B fund to help support portfolio companies through the pandemic

We’re now several weeks into what has become a very big dip for the global economy due to the coronavirus pandemic, but amidst that, we are seeing are some notable pockets of investment activity emerging that will help shape how the future startup landscape will look. Today, one of the biggest venture capital firms in the world announced the closing of a huge fund, money that it will use in large part to help its portfolio businesses weather the storm. Insight, the firm that has backed the likes...
Tags: TC, Funding, Tech, Venture Capital, Shopify, Parekh, Deven Parekh, Jeff Horing, Insight Partners, Horing, Coronavirus, COVID-19


Insight closes $9.5B fund to help support portfolio companies through the pandemic crunch

We’re now several weeks into what has become a very big dip for the global economy due to the coronavirus pandemic, but amidst that, we are seeing are some notable pockets of investment activity emerging that will help shape how the future startup landscape will look. Today, one of the biggest venture capital firms in the world announced the closing of a huge fund, money that it will use in large part to help its portfolio businesses weather the storm. Insight, the firm that has backed the likes...
Tags: TC, Funding, Tech, Venture Capital, Shopify, Parekh, Deven Parekh, Jeff Horing, Insight Partners, Horing, Coronavirus, COVID-19


VenBio Partners Bags $394M to Back More Medicine-Making Biotechs

Investors worried about a recession like venBio Partners’ risk-mitigated approach to venture capital investing. That approach has led new limited partners to join earlier backers in putting nearly $400 million into the San Francisco-based firm’s new fund.VenBio announced Friday it closed its third fund, raising $394 million which it plans to invest using the same guidelines that led it to back 29 biotechs since its inception in 2011.Corey Goodman, venBio co-founder and partner, in 2014 told Xco...
Tags: Startups, Boston, Funding, San Francisco, Trends, Investment, Venture Capital, M&a, Pfizer, Biotech, Financing, Life Sciences, Corey Goodman, National blog main, Boston blog main, Xconomy


Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More

The coronavirus pandemic has shaken the global economy, but three life sciences venture capital firms this week announced new funds totaling nearly $3 billion.ARCH Venture Partners led the pack, adding two funds totaling $1.46 billion to its war chest. Flagship Pioneering bagged $1.1 billion, and venBio Partners reeled in $394 million. Flagship CEO Noubar Afeyan told Xconomy that the pandemic  unexpectedly highlights the need for investment in one of its new thematic areas of interest: “health ...
Tags: Startups, Cancer, Trends, Investment, Venture Capital, National, Novartis, Biotech, Venture Partners, Life Sciences, Abbott, Reata Pharmaceuticals, Amgen, Corey Goodman, Medtronic, Vir


The pendulum will swing away from founder-friendly venture raises

Hello and welcome back to our regular morning look at private companies, public markets and the gray space in between. This morning brought fresh economic bad news for the US economy, with over 700,000 jobs lost in the latest report, despite the window of time measured not including some of March’s worst days, and the data itself not counting as many individuals as it might have; the unemployment rate still rose nearly a full point to 4.4%. The barometer generally expected to rise far higher in ...
Tags: Fundings & Exits, Startups, US, Tech, Venture Capital, PitchBook


Longtime VC Neil Sequeira: funding founders without in-person meetings is ‘quite difficult’

Neil Sequeira was a managing director with General Catalyst for more than 13 years before co-founding early-stage firm Defy several years ago with another veteran of the industry, Trae Vassallo, who’d spent the dozen years prior with Kleiner Perkins. We caught up with Sequeira yesterday afternoon and discussed whether he’s seeing valuations come down and whether he can imagine funding founders who may have an exciting pitch but is unable to meet in-person due to the pandemic. Our chat has ...
Tags: Startups, TC, Funding, Tech, Fundraising, Venture Capital, General Catalyst, Kleiner Perkins, Bay Area, Trae Vassallo, Defy, Neil Sequeira, Sequeira, Extra Crunch, Coronavirus, COVID-19


Flagship Adds $1.1B for New Meds, More AI, & “Health Security”

Flagship Pioneering founder and CEO Noubar Afeyan didn’t know a global pandemic was in the cards for 2020 when he and his team laid out three new thematic areas of focus for the company last fall.One proved eerily prescient: The notion of “health security,” or the development of new products and therapies to treat health concerns before they arise or escalate. On Thursday the Cambridge, MA-based venture capital firm, best known for starting and spinning out biotechs, announced it had added $1.1...
Tags: Startups, Funding, Trends, Investment, Venture Capital, Machine Learning, National, Ai, Biotech, Financing, National Venture Capital Association, Illumina, Life Sciences, Clinical Trials, ARCH Venture Partners, Cambridge MA


ARCH Venture Partners raises $1.46 billion across two funds for biotech investing

Against a backdrop where the life-or-death consequences of biotechnology innovation are becoming increasingly apparent as the world races to develop vaccines and therapies to treat COVID-19, life sciences investor ARCH Venture Partners has raised $1.46 billion in funding to finance new tech development. The two funds, ARCH Venture Fund X and ARCH Venture Fund X Overage, are the latest in the firm’s long line of investment vehicles dedicated to invest in early stage biotechnology companies. “A...
Tags: TC, Money, Entrepreneurship, Finance, Tech, Economy, Venture Capital, Private Equity, Fda, Biotechnology, ARCH Venture Partners, Robert Nelsen, Corporate Finance, Quanterix, Bellerophon, Twist Biosciences


“A perfect storm for first time managers,” say VCs with their own shops (and who have advice)

Until very recently, it had begun to seem like anyone with a thick enough checkbook and some key contacts in the startup world could not only fund companies as an angel investor but even put himself or herself in business as a fund manager. It helped that the world of venture fundamentally changed and opened up as information about its inner workings flowed more freely. It didn’t hurt, either, that many billions of dollars poured into Silicon Valley from outfits and individuals around the globe ...
Tags: Google, Startups, TC, General Motors, Lp, Venture Capital, Silicon Valley, Intuit, Hudson, Felicis Ventures, Ron Conway, Credit Karma, Fika, Ho, Conway, Gosh


Proposed amendments to the Volcker Rule could be a lifeline for venture firms hit by market downturn

In the wake of the financial crisis, Congress passed regulations limiting the types of investments that banks could make into private equity and venture capital funds. As cash strapped investors pull back on commitments to venture funds given the precipitous drop of public market stocks, loosening restrictions on the how banks invest cash could be a lifeline for venture funds. That’s the position that the National Venture Capital Association is taking on the issue sent to the chairs of the Fede...
Tags: TC, Money, Congress, Finance, Virginia, Softbank, Tech, Georgia, Investment, Banking, Economy, New Hampshire, Venture Capital, Wisconsin, Ohio, Private Equity


Venture debt’s new reality: ‘The last thing we want is management walking away from a company’

Maurice Werdegar is the longtime CEO of venture debt shop Western Technology Investment, one of the most active venture debt lenders in the U.S. It’s also one of the older firms, having loaned out money for roughly 40 years to startups that needed to achieve certain milestones, reach profitability or wanted additional runway and didn’t necessarily want to raise a new round (especially if that next round might be at a lower valuation). It’s a needed service and a boon for startups in good time...
Tags: Startups, TC, Entrepreneurship, Funding, Tech, Fundraising, Venture Capital, BDC, Werdegar, Corporate Finance, Western Technology Investment, Venture Debt, Extra Crunch, Coronavirus, COVID-19, Maurice Werdegar


Start-Ups Are Pummeled in the ‘Great Unwinding’

Dozens have laid off thousands, slashed costs and changed their businesses to try to survive the pandemic. All that may not work.
Tags: News, Venture Capital, Relief, Start-ups, Layoffs and Job Reductions, Labor and Jobs, Careers and Professions, Coronavirus (2019-nCoV, Coronavirus Aid, and Economic Security Act (2020


Pandion Pulls In $80M as Ulcerative Colitis Drug Advances in Clinic

Pandion Therapeutics emerged in 2018 aiming to reach clinic trials in two years testing its biologic drugs in autoimmune and inflammatory disorders. The company now has $80 million to support a lead program in early-stage testing and a pipeline of potential treatments.Access Biotechnology and Boxer Capital led the Series B round of funding announced Wednesday.Pandion is developing drugs intended to treat autoimmune diseases by fixing the immune system imbalance that leads to these conditions. T...
Tags: Deals, Startups, Boston, Trends, Investing, Ulcerative Colitis, Venture Capital, Cambridge, Biotech, Life Sciences, Autoimmune Diseases, Polaris Partners, Clinical Trials, Roche, Versant Ventures, National blog main